#49 Equity in Clinical Trials with Sans Thakur: Empowering Female Health, Tackling Gender Bias, Revolutionizing Digital Trials, Equalizing Funding and Accelerating Patient Treatment

Prior to Medable Sans at the helm of Accenture's Global Life Sciences Research, assumed the pivotal role of orchestrating visionary market-shaping strategies and spearheading program execution in therapeutics, digital health, and scientific innovation. With over two decades in the industry, Sans's expertise graced the corridors of more than 30 companies, launching an impressive lineup of 10 groundbreaking products. Her guidance extended even further, advising digital health venture funds and masterfully managing a top 20 pharmaceutical portfolio.

In this episode, she delves deep into the pervasive issue of gender bias in clinical trials unveiling the startling truth about how these trials predominantly focus on Males with little Ethnic Diversity, leading to medicines that may not be optimized for everyone. How in the late 1970s women of childbearing age were excluded from medical research, regardless of their intention or ability to have children, how despite women comprising over half the population, a mere 1% of healthcare research and development is invested in addressing their specific conditions and how both the FDA and EMA have undergone a transformative shift in their perception of digital tools.

Get in touch with Sans Thakur - https://www.linkedin.com/in/sanskritithakur/, https://www.medable.com/

Get in touch with Karandeep Badwal - https://www.linkedin.com/in/karandeepbadwal/

Follow Karandeep on YouTube - https://www.youtube.com/@KarandeepBadwal

Subscribe to the Podcast